Australia markets close in 2 hours 29 minutes

Archer Materials Limited (AXE.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.3900+0.0100 (+2.63%)
As of 12:06PM AEDT. Market open.
Full screen
Previous close0.3800
Bid0.3750 x 1000000
Ask0.3850 x 682300
Day's range0.3800 - 0.3900
52-week range0.3600 - 0.7200
Avg. volume157,942
Market cap102.006M
Beta (5Y monthly)1.19
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Archer Demonstrates Multiplexing Readout for Its Advanced Biochip gFET

    Highlights Archer Materials has demonstrated multiplexing readout for its Biochip by integrating its advanced gFET sensors with newly developed hardware and software that analyse multiple liquid samples on a chip at once.Archer will apply the single-chip multiplexing capability to biologically relevant molecules, which will potentially enable end-users to detect multiple diseases from one single chip.The Biochip designs and devices form the basis of intellectual property that is 100% owned by Ar

  • GlobeNewswire

    Archer’s biochip gFET design for advanced sensing validated by commercial foundry partner

    Image 1 Archer’s advanced gFET chip for advanced biosensing diced from the whole four-inch wafer fabricated in a commercial foundry. Highlights Archer Materials’ commercial foundry partner in the Netherlands has validated its advanced biochip gFET design by manufacturing the chips using whole four-inch wafer semiconductor fabrication processes.The new gFET design for multiplexing was fabricated at a commercial scale foundry.The validation of the new advanced gFET device design and whole wafer ru

  • GlobeNewswire

    Archer further enhances biochip gFET design for advanced sensing and sends to commercial foundry partner

    Highlights Archer Materials has advanced its biochip gFET design to improve its detection and control capabilities which link to the goal of single device multiplexing.The advanced gFET design is aimed at allowing the biochip to handle liquid samples to test for multiple diseases at once on a single chip, with potential for re-use capabilities.Archer has improved its biochip system capabilities towards automated data analysis so end users can extract high quality data with greater efficiency.The